Table 3.
Comparison of selected risk factors in 18- to 30-month±-old children with a positive history for premature CAD and controls (means ± SD); 2nd stage of the study
| Parameter | Positive history (n=18) | Negative history (n=12) | p |
|---|---|---|---|
| TG (mg/dl) | 105.44±69.04 | 83.03±29.26 | <0.05 |
| TC (mg/dl) | 165.56±30.99 | 167.83±33.15 | ns |
| HDL (mg/dl) | 55.46±14.28 | 47.35±11.92 | ns |
| LDL (mg/dl) | 88.96±37.14 | 103,87±32.30 | ns |
| VLDL (mg/dl) | 21.09±13.81 | 16.62±5.85 | <0.05 |
| Apo A1 (mg/dl) | 154.22±18.73 | 147.33±19.90 | ns |
| Apo B (mg/dl) | 73.11±18.82 | 77.58±17.59 | ns |
| Lp (a) (mg/dl) | 18.27±26.11 | 5.89±3.65 | <0.05 |
| Hcy (μmol/L) | 12.20±2.46 | 10.67±2.41 | ns |
| sVCAM-1 (ng/ml) | 1616.11±561.92 | 1516.13±501.75 | ns |
| sICAM-1 (ng/ml) | 391.15±95.28 | 384.31±57.96 | ns |
| sE-selectin (ng/ml) | 58.37±17.17 | 72.57±38.16 | ns |
| IMT (mm) | 0.43±0.04 | 0.39±0.06 | ns |
ns – non-significant